All News
Filter News
Found 808,690 articles
-
The Centre for Aging + Brain Health Innovation and SOMPO Digital Lab partner to accelerate innovation in seniors' care
6/7/2019
CABHI and SOMPO Digital Lab will jointly partner with innovative companies globally to test, validate, disseminate, adopt, and scale promising innovations in the longevity sector.
-
Dr. Thomas Cannell, President and CEO of Sesen Bio, to Host Conference Call to Provide Regulatory Update on Pre-BLA Meeting for Vicinium®
6/7/2019
Sesen Bio announced that Dr. Thomas Cannell, President and CEO will host a conference call on Monday, June 10, 2019 at 8:00 a.m. ET to provide an update on the Company’s meeting with the FDA on June 6, 2019.
-
Imara to Present at the 24th Congress of the European Hematology Association
6/7/2019
Imara Inc. announced that the company will deliver an oral presentation on IMR-687 at the 24th Congress of the European Hematology Association being held from June 13 – 16, 2019, in Amsterdam.
-
ArQule to Present Clinical Data for its BTK Inhibitor, ARQ 531, at the 24th Congress of the European Hematology Association (EHA)
6/7/2019
ArQule, Inc. announced that it will present clinical data from the company-sponsored phase 1 dose escalation study on its BTK inhibitor, ARQ 531, for the treatment of relapsed or refractory B-cell lymphoid malignancies in a poster presentation at the 24th Congress of European Hematology Association (EHA), held from June 13-16, 2019 in Amsterdam.
-
Neptune signs multi-year extraction agreement with Tilray
6/7/2019
Neptune will receive, at its facility in Sherbooke, Quebec, cannabis and hemp biomass from Tilray.
-
Hansjörg Wyss, Harvard M.B.A. '65, Gives Unprecedented Third Major Gift to Harvard to Support the Wyss Institute's Mission to Develop and Commercialize World-Changing Technologies
6/7/2019
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced the latest gift of $131 million from its founding entrepreneur and philanthropist, Hansjörg Wyss.
-
EIP Pharma to Host KOL Breakfast Briefing on Potential of Neflamapimod in Alzheimer's Disease and Dementia with Lewy Bodies
6/7/2019
EIP Pharma, Inc. announced that the Company will host a key opinion leader breakfast briefing focused on the potential of neflamapimod in Alzheimer's disease and Dementia with Lewy bodies on Friday, June 21st, 2019 at 8:00 a.m. ET in New York City.
-
Vitamin D Supplements Do Not Significantly Reduce Risk of Developing Type 2 Diabetes, According to Research Presented Today at the ADA's Scientific Sessions
6/7/2019
D2d is the largest study to examine vitamin D supplementation among people at high risk with sufficient vitamin D levels [07-June-2019] SAN FRANCISCO , June 7, 2019 /PRNewswire/ -- New research shows that daily oral vitamin D supplementation does not effectively reduce the risk of type 2 diabetes among vitamin D-sufficient adults at high risk for developing the diseas
-
Search launched for first patient proven spontaneously cured of Alzheimer's disease, announces Dr. Leslie Norins of Alzheimer's Germ Quest, Inc.
6/7/2019
Has any Alzheimer's disease patient ever been proven cured spontaneously of the usually fatal disease, without medical intervention?
-
Iberostar’s New Coral Lab Opens for World Oceans Day, Offering Hope for the Future of Caribbean Reefs and Oceans Everywhere
6/7/2019
Coral Lab Demonstrates Iberostar Group’s Commitment to Wave of Change Movement
-
FDA permits marketing of first medical device for relief of pain associated with irritable bowel syndrome in patients 11-18 years of age
6/7/2019
The U.S. Food and Drug Administration permitted marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome when combined with other therapies for IBS.
-
Patterson Companies Fourth-Quarter Fiscal 2019 Conference Call Scheduled for Thursday, June 27, 2019
6/7/2019
Patterson Companies announced that it will hold its fiscal 2019 fourth-quarter and year-end conference call on Thursday, June 27, 2019 at 9 a.m. CT.
-
Nonprofit CureDuchenne is Encouraged to See Gene Editing for Duchenne Advance Through Vertex’s Acquisition of Exonics Therapeutics
6/7/2019
Deal will accelerate drug development for Duchenne muscular dystrophy, a rare disease that affects 300,000 boys and young men worldwide
-
Boston Biomedical, Inc. Announces the Continuation of the Phase 3 CanStem303C Study of Napabucasin in Patients with Advanced Colorectal Cancer Following Interim Analysis
6/7/2019
Boston Biomedical, Inc. announced the continuation of the CanStem303C study evaluating the safety and efficacy of investigational agent napabucasin when given in combination with FOLFIRI with or without bevacizumab in patients with advanced colorectal cancer.
-
PartsSource Launches New E-Commerce Platform
6/7/2019
Company Enhances the Online Experience by Offering an Improved E-Commerce Platform for its Healthcare Customers
-
MedMen Expands Market Share in California with Acquisition of Long Beach Retailer
6/7/2019
The Company Adds Flagship Location in Southern California’s Third Largest City
-
Microsure’s MUSA Microsurgery Robot Receives CE-mark
6/7/2019
MUSA is the world’s first surgical robot for open microsurgery.
-
MedPro Healthcare Staffing awards its inaugural Helena Ramsay Soaring Leader Scholarships in Parkland, FL
6/7/2019
MedPro Healthcare Staffing has awarded scholarships to three specially selected students from Marjory Stoneman Douglas High School as part of the Helena Ramsay Soaring Leader Scholarship.
-
Khiron Receives Regulatory Approval for Uruguay Acquisition
6/7/2019
Khiron Life Sciences Corp. announced agreement for the acquisition of NettaGrowth International Inc., which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A., is progressing as planned.
-
VALBIOTIS to Present Novel Data about TOTUM-63 and Metabolic Diseases Prevention at the 2019 Scientific Sessions of the American Diabetes Association
6/7/2019
TOTUM-63 reduces inflammation in visceral adipose tissue, one of the mechanisms leading to type 2 diabetes and metabolic diseases.